Pharmaceutical

Shares of ABIOMED, Inc. (NASDAQ: ABMD) plunged lower by more than 25 percent on Thursday. The company reported its second-quarter results and raised its fiscal 2016 guidance Thursday morning. Traders attributed the selloff to the company's growth profile losing momentum. Shares of Abiomed, a...

Pfizer Inc. (NYSE: PFE) confirmed media reports that the company is in talks with Allergan PLC (NYSE: AGN) over a potential business combination transaction. Pfizer said it is in "preliminary friendly discussions" with Allergan, but offered no assurances that the conversations will...

Shares of Aquinox Pharmaceuticals Inc (NASDAQ: AQXP) skyrocketed more than 350 percent Monday morning, hitting a 52-week high of $55.75. The stock was trading at less than $2 per share last Thursday -- that's not a typo. Midway through Monday's trading, the stock is near the $38 mark. On Friday...

The fickle finger of Wall Street has been unkind to the shares of Johnson & Johnson (NYSE: JNJ) this week, despite an earnings beat. Not only did the company beat EPS expectations by $0.12, ($1.66 vs.1.54), it exceeded revenues ($19.50 billion vs. $18.86 billion), improved sales by nine...

Editor's note on July 28, 2015: Dr. Marlon Fuller is no longer affiliated with BudgetWeed.com. BudgetWeed.com is a Charlotte, North Carolina-based cannabis industry product and service locater. The website, according to its founder and CEO Dr. Marlon Fuller is “a fusion between Yelp and...

The business of chain drugstores has been a veritable model for how just about any retail business should envision itself. Over the past 75 years, chain drugstores have seen staggeringly consistent growth while becoming an increasingly pervasive part of America's cultural landscape. With...

In this momentum-driven market, sector or company-specific news can have a significant impact on the price of individual issues. Wall Street analysts weighing in on the issue may also add to the momentum already in place. An example is Achillion Pharmaceuticals (NASDAQ: ACHN), where all of...

Biotech stocks have been one of the hottest sectors of the market over the last several years and many exchange traded funds have benefitted greatly from their success. The two largest ETFs in this space are the iShares NASDAQ Biotechnology ETF (NASDAQ: IBB) and SPDR S&P Biotech ETF (NYSE:...

On Tuesday morning, Johnson & Johnson (NYSE: JNJ) reported its fourth quarter results. The company announced an EPS of $1.24, beating the consensus estimate by four cents. Revenue of $18.40 billion came in $450 million higher than the consensus estimate. The company benefited from domestic...

Pfizer (NYSE: PFE) has come to a settlement with Israel's Teva Pharmaceutical Industries (NYSE: TEVA), that will allow Teva to to launch a generic version of the anti-impotency drug Viagra in late 2017. While most of the agreement's terms remain confidential, Pfizer says Teva will pay a royalty...

Small-cap pharmaceutical companies are as risky as they come. To combat this, investors look at how insiders and institutions are playing these firms with their significant expertise and inside scoop. Anacor Pharmaceuticals (NASDAQ: ANAC) develops small molecule therapeutics, the majority of...

Shares of Alexion (NASDAQ: ALXN) spiked higher when Bloomberg reported that the pharmaceutical company will be working with Goldman Sachs (NYSE: GS) on a potential takeover by Roche (OTC: RHHBY). Shares of Alexion jumped as high as $120.48, or 10.2 percent on the news. More than 2.5 million...